Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ronit Rosenfeld and David Gur.
Ronit Rosenfeld
Connection Strength
0.887
David Gur
  1. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants. Cell Rep. 2021 09 07; 36(10):109679.
    View in: PubMed
    Score: 0.241
  2. Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice. iScience. 2021 May 21; 24(5):102479.
    View in: PubMed
    Score: 0.235
  3. Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody. Nat Commun. 2021 02 11; 12(1):944.
    View in: PubMed
    Score: 0.232
  4. Implementation of Adenovirus-Mediated Pulmonary Expression of Human ACE2 in HLA Transgenic Mice Enables Establishment of a COVID-19 Murine Model for Assessment of Immune Responses to SARS-CoV-2 Infection. Pathogens. 2021 Jul 26; 10(8).
    View in: PubMed
    Score: 0.060
  5. Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2. JCI Insight. 2021 06 22; 6(12).
    View in: PubMed
    Score: 0.060
  6. Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection. Nano Lett. 2021 06 09; 21(11):4774-4779.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.